跳至主要内容
临床试验/CTRI/2021/10/037626
CTRI/2021/10/037626招募中未知

Prospective evaluation of sequential transarterial chemoembolization and stereotactic body radiation therapy to effectively downstage cirrhotic patients with hepatocellular carcinoma and portal vein invasion before living donor liver transplantation

Institute of liver disease and transplantation0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • a.Age: 18-70 years
  • b.Eastern cooperative oncology group (ECOG) performance status: 0-2
  • c.Child Pugh A and B status
  • d.HCC of any size and any number
  • e.Portal vein tumor thrombus or invasion (Vp1-4)
  • f.No extra-hepatic disease by CECT/MRI and 18FDG/68GaPET scan

排除标准

  • a.Poor performance status (ECOG >2)
  • b.Child Pugh C status
  • c.Mixed tumors such as hepatocholangiocarcinoma
  • d.Previous treatment for HCC
  • e.Extra-hepatic metastatic disease
  • f.Hepatic vein or inferior vena cava involvement
  • g.People unfit for LDLT independent of the liver disease due to poor cardiopulmonary status
  • h.Non-availability of living related liver donor
  • i.Consent withdrawn

研究者

发起方
Institute of liver disease and transplantation

相似试验